New research out of Africa has potentially devastating news for women there, who rely on the convenience and confidentiality of injectable contraception. The study, published Monday in The Lancet Infectious Diseases, indicates that the injectable contraceptive may double their risk of acquiring HIV, and also increases the risk of transmitting it to a male partner.
NPF’s J2J program arm has just completed training for 20 journalists who now are fanning out to cover AIDS Vaccine 2011, the international gathering of scientists seeking a vaccine against HIV. Over two days here in Bangkok, Thailand, our fellows heard from 20 researchers, most of whom are making important presentations at the conference. The briefings and extensive question-and-answer sessions helped prepare our group to report on the news from the conference, including an important development that moves the field significantly ahead.
Thomson Reuters correspondent Sui-lee Wee works in a country where health issues are at the forefront of the public discussion and a matter of international scrutiny. Sui-Lee started out covering the Southeast Asian stock markets before completing her master’s degree in business journalism at New York University in 2008. She now covers politics and general news in China, but also deals with human rights and health issues.
This is a guest post by Kenny Goldberg, health reporter for KPBS News in San Diego. He is a former J2J fellow.
The results of three new studies about the effectiveness of daily use of the medication tenofovir, Truvada and other drugs to prevent transmission of HIV are impressive. The idea that a pill could act as a prophylactic against the spread of the virus has been a longtime dream.
But as anyone who’s been covering the epidemic knows, when it comes to antiretroviral drugs, there is no free lunch. All medications have side effects. As journalists responsible for reporting on advances in the field, we need to communicate those risks and put them in their proper context.
ROME – A wealth of potential story ideas came out of the Rome AIDS conference. This is a list I discussed with people attending a media briefing organized by the IAS prior to the conference. What are the ideas you’d like to share? Fill in the comment box at the end of this post.
The BIG story coming out of the Rome AIDS conference were the results from three separate trials seeking to determine of available drugs used for the treatment of HIV could be used for the prevention of transmission.
Earlier Blog Posts
What the HIV Experience Can Teach the NCD Community
August 1, 2011
Lowering the Cost of AIDS Drugs While Searching for…
July 29, 2011
Three Exciting AIDS Trials
July 25, 2011
Help Finding Missing South African Photographer
April 14, 2011
Impact of the CR11 Budget Deal on Global Health Programs
April 13, 2011